Enoxaparin sodium reduces poststenting MI rates

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1321, 2002-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin sodium recommended as antithrombotic of choice in acute MI

By  

Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Dalteparin sodium vs enoxaparin sodium: DVT/PE rates comparable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 256, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Tenecteplase plus enoxaparin sodium: MI therapy reaches new heights in ASSENT-3

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Adjunctive enoxaparin sodium reduces the short-term incidence of death and nonfatal reinfarction, compared with unfractionated heparin

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Enoxaparin sodium: Haematoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite